(Q38042766)

27 August 2017

title

Arterial, venous and other vascular risk factors in multiple sclerosis (English)

1 reference

27 August 2017

0 references

Bianca Weinstock-Guttman

series ordinal

5

object named as

Bianca Weinstock-Guttman

1 reference

27 August 2017

2

Murali Ramanathan

1 reference

27 August 2017

4

Robert Zivadinov

1 reference

27 August 2017

1

Yuval Karmon

1 reference

27 August 2017

3

Alireza Minagar

1 reference

27 August 2017

publication date

1 October 2012

1 reference

27 August 2017

published in

Neurological Research

1 reference

27 August 2017

volume

34

1 reference

27 August 2017

issue

8

1 reference

27 August 2017

page(s)

754-760

1 reference

Lessons from multiple sclerosis: models, concepts, observations

27 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1179%2F1743132812Y.0000000077

Multiple sclerosis--the plaque and its pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1743132812Y.0000000077

Modeling the cumulative genetic risk for multiple sclerosis from genome-wide association data

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1743132812Y.0000000077

Explaining multiple sclerosis prevalence by ultraviolet exposure: a geospatial analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1743132812Y.0000000077

Shift work at young age is associated with increased risk for multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1743132812Y.0000000077

The place of conventional MRI and newly emerging MRI techniques in monitoring different aspects of treatment outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1743132812Y.0000000077

Abnormal subcortical deep-gray matter susceptibility-weighted imaging filtered phase measurements in patients with multiple sclerosis: a case-control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1743132812Y.0000000077

Recent developments in imaging of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1743132812Y.0000000077

Inflammation, demyelination, and degeneration - recent insights from MS pathology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1743132812Y.0000000077

Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1743132812Y.0000000077

Vascular comorbidity is associated with more rapid disability progression in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1743132812Y.0000000077

Trends in survival and cause of death in Danish patients with multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1743132812Y.0000000077

Underlying cause of death in Danish patients with multiple sclerosis: results from the Danish Multiple Sclerosis Registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1743132812Y.0000000077

Survival and cause of death in multiple sclerosis: a prospective population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1743132812Y.0000000077

Physical activity and self-reported cardiovascular comorbidities in persons with multiple sclerosis: evidence from a cross-sectional analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1743132812Y.0000000077

Blood cholesterol and MRI activity in first clinical episode suggestive of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1743132812Y.0000000077

Paraoxonase 1 activity in different types of multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1743132812Y.0000000077

Serum lipid profiles are associated with disability and MRI outcomes in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1743132812Y.0000000077

Thematic review series: brain Lipids. Cholesterol metabolism in the central nervous system during early development and in the mature animal

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1743132812Y.0000000077

Oxysterols as biomarkers in neurodegenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1743132812Y.0000000077

Intracellular lipid flux and membrane microdomains as organizing principles in inflammatory cell signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1743132812Y.0000000077

The immune system in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1743132812Y.0000000077

Immunology: Oxysterols hold T cells in check

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1743132812Y.0000000077

LXR signaling couples sterol metabolism to proliferation in the acquired immune response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1743132812Y.0000000077

Integration of metabolism and inflammation by lipid-activated nuclear receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1743132812Y.0000000077

Liver X receptor (LXR) mediates negative regulation of mouse and human Th17 differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1743132812Y.0000000077

Cardiovascular disease complications in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1743132812Y.0000000077

Traditional cardiovascular risk factors in rheumatoid arthritis: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1743132812Y.0000000077

Possible contributions of lipoproteins and cholesterol to the pathogenesis of diabetes mellitus type 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1743132812Y.0000000077

Serum lipoprotein levels in patients with neuromyelitis optica elevated but had little correlation with clinical presentations

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1743132812Y.0000000077

Lipid arrays identify myelin-derived lipids and lipid complexes as prominent targets for oligoclonal band antibodies in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1743132812Y.0000000077

Lipid microarrays identify key mediators of autoimmune brain inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1743132812Y.0000000077

Antibodies to sulfatide in cerebrospinal fluid of patients with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1743132812Y.0000000077

Antigen microarrays identify unique serum autoantibody signatures in clinical and pathologic subtypes of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1743132812Y.0000000077

Toll-like receptor 2 and poly(ADP-ribose) polymerase 1 promote central nervous system neuroinflammation in progressive EAE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1743132812Y.0000000077

High levels of 15-oxygenated steroids in circulation of patients with multiple sclerosis: fact or fiction?

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1743132812Y.0000000077

Apolipoproteins in human cerebrospinal fluid

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1743132812Y.0000000077

High-density lipoprotein-associated apolipoprotein A-I: the missing link between infection and chronic inflammation?

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1743132812Y.0000000077

Environmental risk factors for multiple sclerosis. Part II: Noninfectious factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1743132812Y.0000000077

Epidemiology and natural history of multiple sclerosis: new insights

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1743132812Y.0000000077

Vitamin D intake and incidence of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1743132812Y.0000000077

Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1743132812Y.0000000077

1,25-Dihydroxyvitamin D3 reversibly blocks the progression of relapsing encephalomyelitis, a model of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1743132812Y.0000000077

Association of vitamin D metabolite levels with relapse rate and disability in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1743132812Y.0000000077

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1743132812Y.0000000077

Vitamin D and disease prevention with special reference to cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1743132812Y.0000000077

High Prevalence of Vitamin D Inadequacy and Implications for Health

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1743132812Y.0000000077

Inter-dependence of vitamin D levels with serum lipid profiles in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1743132812Y.0000000077

The risk of multiple sclerosis in the U.S.A. in relation to sociogeographic features: a factor-analytic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1743132812Y.0000000077

Effect of low saturated fat diet in early and late cases of multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1743132812Y.0000000077

Review of MS patient survival on a Swank low saturated fat diet

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1743132812Y.0000000077

Double-blind Trial of Linoleate Supplementation of the Diet in Multiple Sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1743132812Y.0000000077

A double-blind controlled trial of long chain n-3 polyunsaturated fatty acids in the treatment of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1743132812Y.0000000077

Low fat dietary intervention with omega-3 fatty acid supplementation in multiple sclerosis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1743132812Y.0000000077

The combination of interferon-beta and HMG-CoA reductase inhibition in multiple sclerosis: enthusiasm lost too soon?

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1743132812Y.0000000077

Oral simvastatin treatment in relapsing-remitting multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1743132812Y.0000000077

Effect of statins on clinical and molecular responses to intramuscular interferon beta-1a

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1743132812Y.0000000077

Simvastatin as add-on therapy to interferon β-1a for relapsing-remitting multiple sclerosis (SIMCOMBIN study): a placebo-controlled randomised phase 4 trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1743132812Y.0000000077

Chronic cerebrospinal venous insufficiency in patients with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1743132812Y.0000000077

The value of cerebral Doppler venous haemodynamics in the assessment of multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1743132812Y.0000000077

Chronic cerebrospinal venous insufficiency in multiple sclerosis: diagnostic, pathogenetic, clinical and treatment perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1743132812Y.0000000077

Anomalous venous blood flow and iron deposition in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1743132812Y.0000000077

The big idea: iron-dependent inflammation in venous disease and proposed parallels in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1743132812Y.0000000077

Hypoperfusion of brain parenchyma is associated with the severity of chronic cerebrospinal venous insufficiency in patients with multiple sclerosis: a cross-sectional preliminary report

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1743132812Y.0000000077

Tracking iron in multiple sclerosis: a combined imaging and histopathological study at 7 Tesla.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1743132812Y.0000000077

Extracranial venous stenosis is an unlikely cause of multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1743132812Y.0000000077

Quantitative ColourDopplerSonography evaluation of cerebral venous outflow: a comparative study between patients with multiple sclerosis and controls.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1743132812Y.0000000077

Comparison of MR and contrast venography of the cervical venous system in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1743132812Y.0000000077

Internal jugular vein duplication: a further truncular malformation in a patient with multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1743132812Y.0000000077

The perfect crime? CCSVI not leaving a trace in MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1743132812Y.0000000077

Progressive multiple sclerosis is not associated with chronic cerebrospinal venous insufficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1743132812Y.0000000077

Extracranial venous hemodynamics in multiple sclerosis: a case-control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1743132812Y.0000000077

No cerebral or cervical venous insufficiency in US veterans with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1743132812Y.0000000077

A prospective open-label study of endovascular treatment of chronic cerebrospinal venous insufficiency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1743132812Y.0000000077

Cardiovascular and Interventional Radiological Society of Europe commentary on the treatment of chronic cerebrospinal venous insufficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1743132812Y.0000000077

"Chronic cerebrospinal venous insufficiency" and multiple sclerosis: critical analysis and first observation in an unselected cohort of MS patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1743132812Y.0000000077

No evidence of chronic cerebrospinal venous insufficiency at multiple sclerosis onset.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1743132812Y.0000000077

Chronic cerebrospinal venous insufficiency and multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1743132812Y.0000000077

Risk of Arterial Cardiovascular Diseases in Patients with Multiple Sclerosis: A Population-Based Cohort Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1743132812Y.0000000077

Detecting oxysterols in the human circulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1743132812Y.0000000077

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1743132812Y.0000000077

10.1179/1743132812Y.0000000077

21 January 2018

Identifiers

DOI

1 reference

27 August 2017

1 reference